Welcome: Guest

log in

Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category
Title Date Price
Bayer
Pipeline, Products ,Performance ,Potential
Oct 2009 £595
Boehringer Ingelheim: Pipeline, Products, Performance, Potential
Sep 2009 £595
Zelos Therapeutics Inc.-Company Report
Sep 2009 £460
Zenotech Laboratories Ltd.-Company Report
Sep 2009 £460
Zealand Pharma A/S-Company Report
Sep 2009 £460
ZARS Pharma-Company Report
Sep 2009 £460
Zambon Company S.p.A.-Company Report
Sep 2009 £460
Zentiva, a.s. (formerly Leciva a.s.)-Company Report
Sep 2009 £460
Zeria Pharmaceutical Co., Ltd.-Company Report
Sep 2009 £460
Cornerstone Therapeutics Inc.-Detailed Product Pipeline
Sep 2009 £475
Crown Laboratories, Inc.-Company Report
Sep 2009 £475
Zhejiang Huahai Pharmaceutical Co.,Ltd-Company Report
Sep 2009 £460
Zahravi Pharmaceutical Company-Company Report
Sep 2009 £460
Zenyaku Kogyo Co. Ltd.-Company Report
Sep 2009 £460
Zyber Pharmaceuticals, Inc.-Company Report
Sep 2009 £460
Eusa Pharma (Europe) Ltd.-Company Report
Sep 2009 £455
Indus Biotech Private Limited-Company Report
Sep 2009 £455
Sucampo Pharmaceuticals, Inc.-Deals & Alliances Report
Sep 2009 £365
Zymenex A/S-Company Report
Sep 2009 £460
ZOLL Medical Corp.-Deals & Alliances Report
Sep 2009 £370
Facet Biotech Corporation-Therapeutic Competitors
Sep 2009 £215
Cleveland Biolabs, Inc.-Deals & Alliances Report
Sep 2009 £380
CombinatoRx Inc-Therapeutic Competitors
Sep 2009 £220
Cellceutix Corporation-Therapeutic Competitors
Sep 2009 £220
Cellceutix Corporation-Detailed Product Pipeline
Sep 2009 £475
Zhuzhou Qianjin Pharmaceutical Co.,Ltd-Company Report
Sep 2009 £460
Cardinal Health, Inc.-Deals & Alliances Report
Sep 2009 £380
Ceragenix Pharmaceuticals, Inc.-Deals & Alliances Report
Sep 2009 £380
CerRx, Inc.-Company Report
Sep 2009 £475
Changzhou Fangyuan Pharmaceutical Co., Ltd.-Company Report
Sep 2009 £475
Charleston Laboratories, Inc.-Company Report
Sep 2009 £475
China Biopharma Inc-Therapeutic Competitors
Sep 2009 £220
Centocor Ortho Biotech Inc.-Company Report
Sep 2009 £475
Celentyx Limited-Company Report
Sep 2009 £475
Obagi Medical Products Inc-Detailed Product Pipeline
Sep 2009 £460
PharmaEssentia Corporation-Company Report
Sep 2009 £460
Biostar Pharmaceuticals, Inc.-Therapeutic Competitors
Sep 2009 £220
Cryo-Cell International Inc.-Deals & Alliances Report
Sep 2009 £380
Combe Incorporated-Company Report
Sep 2009 £475
Consilient Health Ltd.-Company Report
Sep 2009 £475
Camus Pharma Pvt. Ltd.-Company Report
Sep 2009 £475
BioTime, Inc.-Deals & Alliances Report
Sep 2009 £380
BioTime Inc-Therapeutic Competitors
Sep 2009 £220
Biovail Corporation-Therapeutic Competitors
Sep 2009 £220
Calistoga Pharmaceuticals, Inc.-Company Report
Sep 2009 £475
Calmune Corporation-Company Report
Sep 2009 £475
China Biologic Products, Inc.-Detailed Product Pipeline
Sep 2009 £475
China Biologic Products, Inc.-Therapeutic Competitors
Sep 2009 £220
Burzynski Research Institute, Inc-Company Report
Sep 2009 £475
C.B. Fleet Company, Inc.-Company Report
Sep 2009 £475
Zydus Cadila Healthcare Limited-Company Report
Sep 2009 £460
Vemedia B.V.-Company Report
Sep 2009 £460
Bio-Med Private Limited-Company Report
Sep 2009 £475
Bio-K+ International Inc.-Company Report
Sep 2009 £475
BioSphere Medical Inc.-Deals & Alliances Report
Sep 2009 £380
Biostar Pharmaceuticals, Inc.-Detailed Product Pipeline
Sep 2009 £475
BIOALVO-Company Report
Sep 2009 £475
Biokine Therapeutics Ltd.-Company Report
Sep 2009 £475
Biochem Pharmaceutical Industries Ltd.-Company Report
Sep 2009 £475
Bio3 Research S.r.l.-Company Report
Sep 2009 £475
BioClinica, Inc.-Deals & Alliances Report
Sep 2009 £380
BioArctic Neuroscience AB-Company Report
Sep 2009 £475
BioCis Pharma Ltd.-Company Report
Sep 2009 £475
Bial Group-Company Report
Sep 2009 £475
Azaya Therapeutics, Inc.-Company Report
Sep 2009 £475
APEX Pharma S.A.E.-Company Report
Sep 2009 £475
Atra Pharmaceuticals Pvt. Ltd.-Company Report
Sep 2009 £475
Aus Bio Limited-Company Report
Sep 2009 £475
Azevan Pharmaceuticals, Inc.-Company Report
Sep 2009 £475
Advanced in vitro cell technologies, s.l. (Advancell)-Company Report
Sep 2009 £475
Advance Pharmaceutical Co., Ltd.-Company Report
Sep 2009 £475
TomoTherapy Incorporated-Deals & Alliances Report
Sep 2009 £370
Actis Biologics, Inc.-Company Report
Sep 2009 £475
AMDL, Inc.-Deals & Alliances Report
Sep 2009 £380
Adnexus Therapeutics, Inc.-Company Report
Sep 2009 £475
Tragara Pharmaceuticals, Inc.-Company Report
Sep 2009 £460
Transave, Inc.-Company Report
Sep 2009 £460
Trinity Biotech plc-Deals & Alliances Report
Sep 2009 £370
Transport Pharmaceuticals, Inc.-Company Report
Sep 2009 £460
Translational Research, Ltd.-Company Report
Sep 2009 £460
TransDermal Technologies, Inc.-Company Report
Sep 2009 £460
Trigen Pharma International-Company Report
Sep 2009 £460
Trius Therapeutics (formerly Rx3 Pharmaceuticals, Inc.)-Company Report
Sep 2009 £460
Tyco International Ltd.-Deals & Alliances Report
Sep 2009 £370
Twinstrand Therapeutics-Company Report
Sep 2009 £460
Transcept Pharmaceuticals, Inc.-Therapeutic Competitors
Sep 2009 £215
Transcept Pharmaceuticals, Inc.-Detailed Product Pipeline
Sep 2009 £460
UAS Laboratories-Company Report
Sep 2009 £460
Unigene Laboratories Inc.-Deals & Alliances Report
Sep 2009 £370
United Therapeutics Corp.-Deals & Alliances Report
Sep 2009 £370
United Pharmaceuticals-Company Report
Sep 2009 £460
Uni-Bio Science Group Ltd.-Company Report
Sep 2009 £460
UNI PHARMA-Company Report
Sep 2009 £460
Vaishnavi Lifescience Pvt. Ltd.-Company Report
Sep 2009 £460
Validus Pharmaceuticals, Inc.-Company Report
Sep 2009 £460
Vectura Group plc-Company Report
Sep 2009 £460
VectorLogics, Inc.-Company Report
Sep 2009 £460
Varian Inc.-Deals & Alliances Report
Sep 2009 £370
Varian Medical Systems Inc.-Deals & Alliances Report
Sep 2009 £370
YuYu Inc.-Company Report
Sep 2009 £460

Industry Events